VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 4 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,559 | +0.7% | 1,750,655 | +53.7% | 0.03% | +3.2% |
| Q2 2023 | $7,503 | +6.4% | 1,139,091 | +9.7% | 0.03% | 0.0% |
| Q1 2023 | $7,049 | +32.9% | 1,038,842 | +44.6% | 0.03% | +19.2% |
| Q4 2022 | $5,303 | -99.9% | 718,360 | +13.0% | 0.03% | -23.5% |
| Q3 2022 | $6,279,000 | +1972.3% | 635,917 | +2189.9% | 0.03% | +1600.0% |
| Q2 2022 | $303,000 | -92.9% | 27,771 | -92.6% | 0.00% | -88.9% |
| Q1 2022 | $4,251,000 | -36.9% | 376,067 | -12.5% | 0.02% | -28.0% |
| Q4 2021 | $6,740,000 | -24.0% | 429,780 | -17.0% | 0.02% | -26.5% |
| Q3 2021 | $8,866,000 | -31.9% | 517,599 | -14.4% | 0.03% | -30.6% |
| Q2 2021 | $13,010,000 | -9.0% | 604,838 | -36.5% | 0.05% | -12.5% |
| Q1 2021 | $14,304,000 | +9.8% | 952,477 | -4.0% | 0.06% | +12.0% |
| Q4 2020 | $13,032,000 | +24.0% | 991,679 | -8.8% | 0.05% | +13.6% |
| Q3 2020 | $10,508,000 | -14.2% | 1,087,893 | +1.6% | 0.04% | -17.0% |
| Q2 2020 | $12,245,000 | +1.3% | 1,070,266 | -8.3% | 0.05% | -23.2% |
| Q1 2020 | $12,086,000 | -25.3% | 1,166,768 | +18.4% | 0.07% | -5.5% |
| Q4 2019 | $16,171,000 | +49.4% | 985,517 | +20.9% | 0.07% | +58.7% |
| Q3 2019 | $10,825,000 | +38.4% | 815,062 | +46.8% | 0.05% | +21.1% |
| Q2 2019 | $7,824,000 | -32.1% | 555,270 | -11.3% | 0.04% | -24.0% |
| Q1 2019 | $11,523,000 | -0.9% | 626,287 | +40.7% | 0.05% | -13.8% |
| Q4 2018 | $11,628,000 | +156.6% | 445,050 | +125.4% | 0.06% | +205.3% |
| Q3 2018 | $4,531,000 | +425.6% | 197,411 | +336.0% | 0.02% | +375.0% |
| Q2 2018 | $862,000 | +459.7% | 45,274 | +381.7% | 0.00% | +300.0% |
| Q2 2017 | $154,000 | -98.0% | 9,399 | -98.3% | 0.00% | -97.1% |
| Q1 2017 | $7,703,000 | -64.8% | 550,306 | -59.9% | 0.04% | -67.0% |
| Q4 2016 | $21,863,000 | +186.7% | 1,370,655 | +199.1% | 0.11% | +178.9% |
| Q3 2016 | $7,626,000 | +355.3% | 458,284 | +206.2% | 0.04% | +322.2% |
| Q2 2016 | $1,675,000 | +1701.1% | 149,689 | +1243.1% | 0.01% | – |
| Q1 2016 | $93,000 | +675.0% | 11,145 | +972.7% | 0.00% | – |
| Q3 2015 | $12,000 | – | 1,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |